The TOLLIP polymorphism has been deeply investigated in the pathogenesis and prognosis of idiopathic pulmonary fibrosis (IPF) and has been reported in small cohorts with conflicting results to be associated with treatment response (65–68). This evidence concerns the gene TOLLIP and idiopathic pulmonary fibrosis.